Question On Notice No. 3 asked in the Legislative Council on 4 May 2021 by Hon Nick Goiran
Question Directed to the: Minister for Mental Health representing the Minister for Health
Parliament: 41 Session: 1
Question
(1) How
many children and adolescents received treatment at the Perth Children's Hospital
Gender Diversity Service in the 2016, 2017, 2018, 2019 and 2020 calendar years?
(2) What
constitutes ‘treatment’ for the numbers provided in (1)?
(3) How
many children and adolescents commenced stage one puberty blocker treatment at
the Perth Children's Hospital Gender Diversity Service in the 2016, 2017, 2018,
2019, 2020 calendar years?
(4) How
many children are currently receiving stage one puberty blocker treatment at
the Perth Children's Hospital Gender Diversity Service?
(5) How
many children commenced stage two cross sex hormone treatment at the Perth
Children's Hospital Gender Diversity Service in the 2016, 2017, 2018, 2019,
2020 calendar years?
(6) How
many children and adolescents are currently receiving stage two cross sex
hormone treatment at the Perth Children's Hospital Gender Diversity Service?
(7) What
was the age of the youngest child to receive treatment at the Perth Children’s
Hospital in each of the years 2016, 2017, 2018, 2019 and 2020?
(8) What
is the age of the youngest child who is currently receiving treatment at the
Perth Children's Hospital Gender Diversity Service?
Answered on 1 June 2021
I am advised:
(1)
Year
|
Stage One
|
Stage Two
|
2016
|
14
|
7
|
2017
|
28
|
17
|
2018
|
47
|
21
|
2019
|
47
|
38
|
2020
|
49
|
47
|
(2) ‘Treatment’ is defined as those patients who are pubertal and who are treated with puberty suppression (“Stage One”) or estrogen or testosterone (“Stage Two”).
(3)
Year
|
Commenced Stage One
|
2016
|
14
|
2017
|
22
|
2018
|
35
|
2019
|
28
|
2020
|
25
|
(4) 44 currently receiving Stage One puberty blocker treatment.
(5)
Year
|
Commenced Stage Two
|
2016
|
6
|
2017
|
10
|
2018
|
15
|
2019
|
31
|
2020
|
29
|
(6) 43 currently receiving Stage Two cross sex hormone treatment.
(7)
Year
|
Stage One
|
Stage Two
|
2016
|
9 years 2 mths
|
15 years 2 mths
|
2017
|
12 years 8 mths
|
16 years 2 mths
|
2018
|
10 years 8 mths
|
15 years 9 mths
|
2019
|
10 years 10 mths
|
15 years 10 mths
|
2020
|
10 years 11 mths
|
15 years 1 mth
|
(8) Youngest patient currently receiving puberty suppression (Stage One): 11 years 4 months.
Youngest patient currently receiving hormone therapy (Stage Two): 15 years 5 months.